Читать книгу Canine and Feline Epilepsy - Luisa De Risio - Страница 61

Alves, L., Hülsmeyer, V., Jaggy, A., Fischer, A., Leeb, T. and Drögemüller, M. (2011) Polymorphisms in the ABCB1 gene in phenobarbital responsive and resistant idiopathic epileptic Border Collies. Journal of Veterinary Internal Medicine 25, 484–489.

Armijo, J.A., Shushtarian, M., Valdizan, E.M., Cuadrado, A., de las Cuevas, I. and Adin, J. (2005) Ion channels and epilepsy. Current Pharmaceutical Design 11, 1975–2003.

Aronica, E., Gorter, J.A., Jansen, G.H., van Veelen, C.W., van Rijen, P.C., Leenstra, S., Ramkema, M., Scheffer, G.L., Scheper, R.J. and Troost, D. (2003) Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors. Neuroscience 118, 417–429.

Arrol, L., Penderis, J., Garosi, L., Cripps, P., Gutierrez-Quintana, R. and Goncalves, R. (2012) Aetiology and long-term outcome of juvenile epilepsy in 136 dogs. Veterinary Record 170, 335.

Arts, W.F., Brouwer, O.F., Peters, A.C., Stroink, H., Peeters, E.A., Schmitz, P.I., van Donselaar, C.A. and Geerts, A.T. (2004) Course and prognosis of childhood epilepsy: 5-year follow-up of the Dutch study of epilepsy in childhood. Brain 127, 1774–1784.

Bankstahl, J.P., Hoffmann, K., Bethmann, K. and Löscher, W. (2008) Glutamate is critically involved in seizure-induced overexpression of P-glycoprotein in the brain. Neuropharmacology 54, 1006–1016.

Basic, S., Hajnsek, S., Bozina, N., Filipcic, I., Sporis, D., Mislov, D. and Posavec, A. (2008) The influence of C3435T polymorphism of ABCB1 gene on penetration of phenobarbital across the blood-brain barrier in patients with generalized epilepsy. Seizure 17, 524–530.

Bauer, B., Hartz, A.M., Pekcec, A., Toellner, K., Miller, D.S. and Potschka, H. (2008) Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling. Molecular Pharmacology 73, 1444–1453.

Berendt, M., Gredal, H., Pedersen, L.G., Alban, L. and Alving, J. (2002) A cross-sectional study of epilepsy in Danish Labrador Retrievers: prevalence and selected risk factors. Journal of Veterinary Internal Medicine 16, 262–268.

Berendt, M., Gredal, H., Ersbøll, A.K. and Alving, J. (2007) Premature death, risk factors, and life patterns in dogs with epilepsy. Journal of Veterinary Internal Medicine 21, 754–759.

Berendt, M., Gulløv, C.H., Christensen, S.L.K., Gudmundsdottir, H., Gredal, H., Fredholm, M. and Alban, L. (2008) Prevalence and characteristics of epilepsy in the Belgian shepherd variants Groenendael and Tervueren born in Denmark 1995-2004. Acta Veterinaria Scandinavica 50, 51.

Berg, A.T., Levy, S.R., Testa, F.M. and DSouza, R. (2009) Remission of epilepsy after two drug failures in children: a prospective study. Annals of Neurology 65, 510–509.

Boothe, D.M., Dewey, C. and Carpenter, D.M. (2012) Comparison of phenobarbital with bromide as a first-choice antiepileptic drug for treatment of epilepsy in dogs. Journal of the American Veterinary Medical Association 240, 1073–1083.

Brandt, C., Bethmann, K., Gastens, A.M. and Löscher, W. (2006) The multidrug transporter hypothesis of drug resistance in epilepsy: Proof-of-principle in a rat model of temporal lobe epilepsy. Neurobiology of Disease 24, 202–211.

Brandt, C., Glien, M., Gastens, A.M., Fedrowitz, M., Bethmann, K., Volk, H.A., Potschka, H. and Löscher, W. (2007) Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats. Neuropharmacology 53, 207–221.

Brini, E., Gandini, G., Crescio, I., Fatzer, R. and Casalone, C. (2004) Necrosis of hippocampus and piriform lobe: clinical and neuropathological findings in two Italian cats. Journal of Feline Medicine and Surgery 6, 377–381.

Casal, M.L., Munuve, R.M., Janis, M.A., Werner, P. and Henthorn, P.S. (2006) Epilepsy in Irish Wolfhounds. Journal of Veterinary Internal Medicine 20, 131–135.

Chandler, K. (2006) Canine epilepsy: what can we learn from human seizure disorders? The Veterinary Journal 172, 207–217.

Chang, Y., Mellor, D.J. and Anderson, T.J. (2006) Idiopathic epilepsy in dogs: owners’ perspectives on management with phenobarbitone and/or potassium bromide. Journal of Small Animal Practice 47, 574–581.

Cowan, L.D. (2002) The epidemiology of the epilepsies in children. Mental Retardation and Developmental Disabilities Research Reviews 8, 171–181.

Dalmau, J., Gleichman, A.J., Hughes, E.G., Rossi, J.E., Peng, X., Lai, M., Dessain, S.K., Rosenfeld, M.R., Balice-Gordon, R. and Lynch, D.R. (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurology 7, 1091–1098.

Dewey, C.W., Guiliano, R., Boothe, D.M., Berg, J.M., Kortz, G.D., Joseph, R.J. and Budsberg, S.C. (2004) Zonisamide therapy for refractory idiopathic epilepsy in dogs. Journal of the American Animal Hospital Association 40, 285–291.

Dewey, C.W., Cerda-Gonzalez, S., Levine, J.M., Badgley, B.L., Ducoté, J.M., Silver, G.M., Cooper, J.J., Packer, R.A. and Lavely, J.A. (2009) Pregabalin as an adjunct to phenobarbital, potassium bromide, or a combination of phenobarbital and potassium bromide for treatment of dogs with suspected idiopathic epilepsy. Journal of the American Veterinary Medical Association 235, 1442–1449.

Elsharkawy, A.E., May, T., Thorbecke, R. and Ebner, A. (2009) Predictors of quality of life after resective extratemporal epilepsy surgery in adults in long-term follow-up. Seizure 18, 498–503.

Fatzer, R., Gandini, G., Jaggy, A., Doherr, M. and Vandevelde, M. (2000) Necrosis of hippocampus and piri-form lobe in 38 domestic cats with seizures: a retrospective study on clinical and pathologic findings. Journal of Veterinary Internal Medicine 14, 100–104.

Fluehmann, G., Doherr, M.G. and Jaggy, A. (2006) Canine neurological diseases in a referral hospital population between 1989 and 2000 in Switzerland. Journal of Small Animal Practice 47, 582–587.

Fromm, M.F. (2000) P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs. International Journal of Clinical Pharmacology and Therapeutics 38, 69–74.

Gullov, C.H., Toft, N., Baadsager, M.M. and Berendt, M. (2011) Epilepsy in the Petit Basset Griffon Vendeen: prevalence, semiology, and clinical phenotype. Journal of Veterinary Internal Medicine 25, 1372–1378.

Heynold, Y., Faissler, D., Steffen, F. and Jaggy, A. (1997) Clinical, epidemiological and treatment results of idiopathic epilepsy in 54 labrador retrievers: a long-term study. Journal of Small Animal Practice 38, 7–14.

Hoffmann, K., Gastens, A.M., Volk, H.A. and Löscher, W. (2006) Expression of the multidrug transporter MRP2 in the blood-brain barrier after pilocarpine-induced seizures in rats. Epilepsy Research 69, 1–14.

Hülsmeyer, V., Zimmermann, R., Brauer, C., Sauter-Louis, C. and Fischer, A. (2010) Epilepsy in Border Collies: clinical manifestation, outcome, and mode of inheritance. Journal of Veterinary Internal Medicine 24, 171–178.

Jaggy, A., Faissler, D., Gaillard, C., Srenk, P. and Graber, H. (1998) Genetic aspects of idiopathic epilepsy in Labrador retrievers. Journal of Small Animal Practice 39, 275–280.

Johnson, M.R. and Shorvon, S.D. (2011) Heredity in epilepsy: neurodevelopment, comorbidity, and the neurological trait. Epilepsy and Behavior 22, 421–427.

Jokinen, T.S., Metsähonkala, L., Bergamasco, L., Viitmaa, R., Syrjä, P., Lohi, H., Snellman, M., Jeserevics, J. and Cizinauskas, S. (2007) Benign familial juvenile epilepsy in Lagotto Romagnolo dogs. Journal of Veterinary Internal Medicine 21, 464–471.

Kathmann, I., Jaggy, A., Busato, A., Bartschi, M. and Gaillard, C. (1999) Clinical and genetic investigations of idiopathic epilepsy in the Bernese mountain dog. Journal of Small Animal Practice 40, 319–325.

Kearsley-Fleet, L., ONeill, D.G., Volk, H.A., Church, D.B. and Brodbelt, D.C. (2013) Prevalence and risk factors for canine epilepsy of unknown origin in the UK. Veterinary Record 172(13), 338.

Kennerly, E.M., Idaghdour, Y., Olby, N.J., Muñana, K.R. and Gibson, G. (2009) Pharmacogenetic association study of 30 genes with phenobarbital drug response in epileptic dogs. Pharmacogenetics and Genomics 19, 911–922.

Kuwabara, T., Hasegawa, D., Kobayashi, M., Fujita, M. and Orima, H. (2010) Clinical magnetic resonance volumetry of the hippocampus in 58 epileptic dogs. Veterinary Radiology and Ultrasound 51, 485–490.

Kwan, P. and Brodie, M.J. (2000) Early identification of refractory epilepsy. The New England Journal of Medicine 342, 314–319.

Kwan, P., Sills, G.J., Butler, E., Gant, T.W., Meldrum, B.S. and Brodie, M.J. (2002) Regional expression of multidrug resistance genes in genetically epilepsy-prone rat brain after a single audiogenic seizure. Epilepsia 43, 1318–1323.

Kwan, P., Poon, W.S., Ng, H.K., Kang, D.E., Wong, V., Ng, P.W., Lui, C.H., Sin, N.C., Wong, K.S. and Baum, L. (2008) Multidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, and SCN3A: correlation among phenotype, genotype, and mRNA expression. Pharmacogenetics and Genomics 18, 989–998.

Kwan, P., Arzimanoglou, A., Berg, A.T., Brodie, M.J., Allen Hauser, W., Mathern, G., Moshé, S.L., Perucca, E., Wiebe, S. and French, J. (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51, 1069–1077.

Kwan, P., Schachter, S.C. and Brodie, M.J. (2011) Drug-resistant epilepsy. The New England Journal of Medicine 365, 919–926.

Lancaster, E., Lai, M., Peng, X., Hughes, E., Constantinescu, R., Raizer, J., Friedman, D., Skeen, M.B., Grisold, W., Kimura, A., Ohta, K., Iizuka, T., Guzman, M., Graus, F., Moss, S.J., Balice-Gordon, R. and Dalmau, J. (2010) Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurology 9, 67–76.

Löscher, W. and Brandt, C. (2010) High seizure frequency prior to antiepileptic treatment is a predictor of pharmacoresistant epilepsy in a rat model of temporal lobe epilepsy. Epilepsia 51, 89–97.

Löscher, W. and Potschka, H. (2002) Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. The Journal of Pharmacology and Experimental Therapeutics 301, 7–14.

Löscher, W. and Potschka, H. (2005) Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases. Progress in Neurobiology 76, 22–76.

Masuyama, H., Suwaki, N., Tateishi, Y., Nakatsukasa, H., Segawa, T. and Hiramatsu, Y. (2005) The pregnane X receptor regulates gene expression in a ligand- and promoter-selective fashion. Molecular Endocrinology 19, 1170–1180.

McKnight, K., Jiang, Y., Hart, Y., Cavey, A., Wroe, S., Blank, M., Shoenfeld, Y., Vincent, A., Palace, J. and Lang, B. (2005) Serum antibodies in epilepsy and seizure-associated disorders. Neurology 65, 1730–1736.

Mealey, K.L., Bentjen, S.A., Gay, J.M. and Cantor, G.H. (2001) Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics 11, 727–733.

Miller, D.S. (2010) Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier. Trends in Pharmacological Sciences 31, 246–254.

Monteiro, R., Adams, V., Keys, D. and Platt, S.R. (2012) Canine idiopathic epilepsy: prevalence, risk factors and outcome associated with cluster seizures and status epilepticus. Journal of Small Animal Practice 53, 526–533.

Muñana, K.R., Zhang, D. and Patterson, E.E. (2010) Placebo effect in canine epilepsy trials. Journal of Veterinary Internal Medicine 24, 166–170.

Muñana, K.R., Nettifee-Osborne, J.A., Bergman, R.L., Jr and Mealey, K.L. (2012a) Association between ABCB1 genotype and seizure outcome in collies with epilepsy. Journal of Veterinary Internal Medicine 26, 1358–1364.

Muñana, K.R., Thomas, W.B., Inzana, K.D., Nettifee-Osborne, J.A., McLucas, K.J., Olby, N.J., Mariani, C.J. and Early, P.J. (2012b) Evaluation of levetiracetam as adjunctive treatment for refractory canine epilepsy: a randomized, placebo-controlled, crossover trial. Journal of Veterinary Internal Medicine 26, 341–348.

Pakozdy, A., Halasz, P., Klang, A., Bauer, J., Leschnik, M., Tichy, A., Thalhammer, J.G., Lang, B. and Vincent, A. (2013) Suspected Limbic Encephalitis and Seizure in Cats Associated with Voltage-Gated Potassium Channel (VGKC) Complex Antibody. Journal of Veterinary Internal Medicine 27, 212–214.

Pardridge, W.M. (1999) Blood-brain barrier biology and methodology. Journal of Neurovirology 5, 556–569.

Pekcec, A., Unkruer, B., Schlichtiger, J., Soerensen, J., Hartz, A.M., Bauer, B., van Vliet, E.A., Gorter, J.A. and Potschka, H. (2009a) Targeting prostaglandin E2 EP1 receptors prevents seizure-associated P-glycoprotein up-regulation. The Journal of Pharmacology and Experimental Therapeutics 330, 939–947.

Pekcec, A., Unkruer, B., Stein, V., Bankstahl, J.P., Soerensen, J., Tipold, A., Baumgartner, W. and Potschka, H. (2009b) Over-expression of P-glycoprotein in the canine brain following spontaneous status epilepticus. Epilepsy Research 83, 144–151.

Penning, V.A., Connolly, D.J., Gajanayake, I., McMahon, L.A., Luis Fuentes, V., Chandler, K.E. and Volk, H.A. (2009) Seizure-like episodes in 3 cats with intermittent high-grade atrioventricular dysfunction. Journal of Veterinary Internal Medicine 23, 200–205.

Picot, M.C., Baldy-Moulinier, M., Daures, J.P., Dujols, P. and Crespel, A. (2008) The prevalence of epilepsy and pharmacoresistant epilepsy in adults: a population-based study in a Western European country. Epilepsia 49, 1230–1238.

Placencia, M., Sander, J.W., Shorvon, S.D., Roman, M., Alarcon, F., Bimos, C. and Cascante, S. (1993) Antiepileptic drug treatment in a community health care setting in northern Ecuador: a prospective 12-month assessment. Epilepsy Research 14, 237–244.

Platt, S.R., Adams, V., Garosi, L.S., Abramson, C.J., Penderis, J., De Stefani, A. and Matiasek, L. (2006) Treatment with gabapentin of 11 dogs with refractory idiopathic epilepsy. Veterinary Record 159, 881–884.

Podell, M. and Fenner, W.R. (1993) Bromide therapy in refractory canine idiopathic epilepsy. Journal of Veterinary Internal Medicine 7, 318–327.

Potschka, H. (2010) Modulating P-glycoprotein regulation: future perspectives for pharmacoresistant epilepsies? Epilepsia 51, 1333–1347.

Potschka, H. (2012) Role of CNS efflux drug transporters in antiepileptic drug delivery: Overcoming CNS efflux drug transport. Advanced Drug Delivery Reviews 64, 943–952.

Potschka, H., Fedrowitz, M. and Löscher, W. (2002) P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats. Neuroscience Letters 327, 173–176.

Potschka, H., Volk, H.A. and Löscher, W. (2004) Pharmacoresistance and expression of multidrug transporter P-glycoprotein in kindled rats. Neuroreport 15, 1657–1661.

Rao, V.V., Dahlheimer, J.L., Bardgett, M.E., Snyder, A.Z., Finch, R.A., Sartorelli, A.C. and Piwnica-Worms, D. (1999) Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. Proceedings of the National Academy 96, 3900–3905.

Regesta, G. and Tanganelli, P. (1999) Clinical aspects and biological bases of drug-resistant epilepsies. Epilepsy Research 34, 109–122.

Remy, S., Gabriel, S., Urban, B.W., Dietrich, D., Lehmann, T.N., Elger, C.E., Heinemann, U. and Beck, H. (2003) A novel mechanism underlying drug resistance in chronic epilepsy. Annals of Neurology 53, 469–479.

Sander, J.W. and Shorvon, S.D. (1996) Epidemiology of the epilepsies. Journal of Neurology, Neurosurgery, and Psychiatry 61, 433–443.

Schinkel, A.H., Smit, J.J., van Tellingen, O., Beijnen, J.H., Wagenaar, E., van Deemter, L., Mol, C.A., van der Valk, M.A., Robanus-Maandag, E.C. and te Riele, H.P. (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77, 491–502.

Schinkel, A.H., Wagenaar, E., Mol, C.A. and van Deemter, L. (1996) P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. Journal of Clinical Investigation 97, 2517–2524.

Schmied, O., Scharf, G., Hilbe, M., Michal, U., Tomsa, K. and Steffen, F. (2008) Magnetic resonance imaging of feline hippocampal necrosis. Veterinary Radiology and Ultrasound 49, 343–349.

Schrickx, J.A. and Fink-Gremmels, J. (2008) Implications of ABC transporters on the disposition of typical veterinary medicinal products. European Journal of Pharmacology 585, 510–519.

Schwartz-Porsche, D. (1986) Epidemiological, clinical and pharmacokinetic studies in spontaneously epileptic dogs and cats. Proceedings of the American College of Veterinary Internal Medicine, pp. 1161–1163.

Schwartz-Porsche, D., Löscher, W. and Frey, H.H. (1985) Therapeutic efficacy of phenobarbital and primidone in canine epilepsy: a comparison. Journal of Veterinary Pharmacology and Therapeutics 8, 113–119.

Seppala, E.H., Jokinen, T.S., Fukata, M., Fukata, Y., Webster, M.T., Karlsson, E.K., Kilpinen, S.K., Steffen, F., Dietschi, E., Leeb, T., Eklund, R., Zhao, X., Rilstone, J.J., Lindblad-Toh, K., Minassian, B.A. and Lohi, H. (2011) LGI2 truncation causes a remitting focal epilepsy in dogs. PLoS Genetics 7, e1002194.

Shihab, N., Bowen, J. and Volk, H.A. (2011) Behavioral changes in dogs associated with the development of idiopathic epilepsy. Epilepsy and Behavior 21, 160–167.

Shukla, S.J., Sakamuru, S., Huang, R., Moeller, T.A., Shinn, P., Vanleer, D., Auld, D.S., Austin, C.P. and Xia, M. (2011) Identification of clinically used drugs that activate pregnane X receptors. Drug Metabolism and Disposition: the Biological Fate of Chemicals 39, 151–159.

Sisodiya, S.M., Lin, W.R., Harding, B.N., Squier, M.V. and Thom, M. (2002) Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy. Brain 125, 22–31.

Spector, R. (2000) Drug transport in the mammalian central nervous system: multiple complex systems. A critical analysis and commentary. Pharmacology 60, 58–73.

Tishler, D.M., Weinberg, K.I., Hinton, D.R., Barbaro, N., Annett, G.M. and Raffel, C. (1995) MDR1 gene expression in brain of patients with medically intractable epilepsy. Epilepsia 36, 1–6.

Trepanier, L.A., Van Schoick, A., Schwark, W.S. and Carrillo, J. (1998) Therapeutic serum drug concentrations in epileptic dogs treated with potassium bromide alone or in combination with other anticonvulsants: 122 cases (1992-1996). Journal of the American Veterinary Medical Association 213, 1449–1453.

Vincent, A., Irani, S.R. and Lang, B. (2010) The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins. Current Opinion in Neurology 23, 144–150.

Volk, H.A. and Löscher, W. (2005) Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures. Brain 128, 1358–1368.

Volk, H.A., Burkhardt, K., Potschka, H., Chen, J., Becker, A. and Löscher, W. (2004a) Neuronal expression of the drug efflux transporter P-glycoprotein in the rat hippocampus after limbic seizures. Neuroscience 123, 751–759.

Volk, H.A., Potschka, H. and Löscher, W. (2004b) Increased expression of the multidrug transporter P-glycoprotein in limbic brain regions after amygdala-kindled seizures in rats. Epilepsy Research 58, 67–79.

Volk, H.A., Arabadzisz, D., Fritschy, J.M., Brandt, C., Bethmann, K. and Löscher, W. (2006) Antiepileptic drug-resistant rats differ from drug-responsive rats in hippocampal neurodegeneration and GABA(A) receptor ligand binding in a model of temporal lobe epilepsy. Neurobiology of Disease 21, 633–646.

Volk, H.A., Matiasek, L.A., Luján Feliu-Pascual, A., Platt, S.R. and Chandler, K.E. (2008) The efficacy and tolerability of levetiracetam in pharmacoresistant epileptic dogs. The Veterinary Journal 176, 310–319.

von Klopmann, T., Rambeck, B. and Tipold, A. (2007) Prospective study of zonisamide therapy for refractory idiopathic epilepsy in dogs. Journal of Small Animal Practice 48, 134–138.

Voss, L.J., Jacobson, G., Sleigh, J.W., Steyn-Ross, A. and Steyn-Ross, M. (2009) Excitatory effects of gap junction blockers on cerebral cortex seizure-like activity in rats and mice. Epilepsia 50(8), 1971–1978.

Waldbaum, S. and Patel, M. (2010) Mitochondria, oxidative stress, and temporal lobe epilepsy. Epilepsy Research 88, 23–45.

Weissl, J., Hülsmeyer, V., Brauer, C., Tipold, A., Koskinen, L.L., Kyostila, K., Lohi, H., Sauter-Louis, C., Wolf, M. and Fischer, A. (2012) Disease progression and treatment response of idiopathic epilepsy in Australian Shepherd dogs. Journal of Veterinary Internal Medicine 26, 116–125.

Wessmann, A., Volk, H.A., Parkin, T., Ortega, M. and Anderson, T.J. (2012) Living with canine idiopathic epilepsy: A questionnaire-based evaluation of quality of life. Journal of Veterinary Internal Medicine 26, 1.